患有查尔斯·博内综合征患者的雌激素与视幻觉
Estrogen and visual hallucinations in a patient with Charles Bonnet syndrome.
作者信息
Fernandes L H, Scassellati-Sforzolini B, Spaide R F
机构信息
LuEsther T. Mertz Retina Research Laboratory, Manhattan Eye, Ear, and Throat Hospital, New York, NY, USA.
出版信息
Am J Ophthalmol. 2000 Mar;129(3):407. doi: 10.1016/s0002-9394(99)00424-9.
PURPOSE
To describe the occurrence of visual hallucinations in a patient with Charles Bonnet syndrome associated with estrogen intake.
METHOD
Case report.
RESULTS
An 84-year-old woman with poor visual acuity secondary to bilateral, nonexudative, age-related macular degeneration had nonthreatening visual hallucinations 2 weeks after starting oral estrogen for osteoporosis. The estrogen was stopped, and the hallucinations subsided. The patient was given estrogen twice more and each time the hallucinations recurred.
CONCLUSION
We report a case of Charles Bonnet syndrome associated with estrogen intake in an 84-year-old woman. Estrogen may have promoted release phenomena and triggered the hallucinatory episodes in our patient.
目的
描述一名患有与雌激素摄入相关的查尔斯·邦尼特综合征患者出现视幻觉的情况。
方法
病例报告。
结果
一名84岁女性，因双侧非渗出性年龄相关性黄斑变性导致视力不佳，在开始口服雌激素治疗骨质疏松症2周后出现无威胁性视幻觉。停用雌激素后，幻觉消退。该患者又两次服用雌激素，每次幻觉均复发。
结论
我们报告了一例84岁女性与雌激素摄入相关的查尔斯·邦尼特综合征病例。雌激素可能促进了释放现象并引发了我们患者的幻觉发作。
Zotero 插件